Citation Impact
Citing Papers
Binding of the NG2 Proteoglycan to Type VI Collagen and Other Extracellular Matrix Molecules
1996
Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans
1992
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
1997 StandoutScience
Notch signalling controls pancreatic cell differentiation
1999 StandoutNatureNobel
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
1991 Standout
Altered metabolism of thrombospondin by Chinese hamster ovary cells defective in glycosaminoglycan synthesis.
1988
Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans.
1985
Cell surface proteoglycan of mammary epithelial cells. Protease releases a heparan sulfate-rich ectodomain from a putative membrane-anchored domain.
1985
Syndecans: multifunctional cell-surface co-receptors
1997
Neurite growth-promoting protein (amphoterin, p30) binds syndecan
1992
Basal cell carcinoma xenografts in nude mice: Studies on epithelial differentiation and stromal relationships
1988
Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts.
1990
Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1.
1994
A Visualizable Chain‐Terminating Inhibitor of Glycosaminoglycan Biosynthesis in Developing Zebrafish
2014 StandoutNobel
Association of laminin with heparan and chondroitin sulfate-bearing proteoglycans in neurite-promoting factor complexes from rat schwannoma cells
1987
Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells.
1995
Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors
1990
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
1989 Standout
CD44 is the principal cell surface receptor for hyaluronate
1990 Standout
Current and Future Drug Targets in Weight Management
2010
Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures
2006
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
2004 StandoutNature
Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2
1998
Chronic Venous Disease
2006 Standout
Age-Related Macular Degeneration
2008 Standout
Expression Cloning and Receptor Pharmacology of Human Calcitonin Receptors from MCF-7 Cells and Their Relationship to Amylin Receptors
1997
The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells
2008
Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy
2010
Beyond Cholesterol
1989 Standout
Heparan Sulfate Proteoglycans as Adhesive and Anti-invasive Molecules
1998
Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide
2001
Treatment of Obesity with Celastrol
2015 Standout
Dynamic control over cell adhesive properties using molecular-based surface engineering strategies
2009 StandoutNobel
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
1998
Radioembolization with Yttrium-90 Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties
2000
Self-association of N-Syndecan (Syndecan-3) Core Protein Is Mediated by a Novel Structural Motif in the Transmembrane Domain and Ectodomain Flanking Region
1995
Pathophysiology of Premature Skin Aging Induced by Ultraviolet Light
1997 Standout
Suppression of Syndecan-1 Expression in Endothelial Cells by Tumor Necrosis Factor-α
1996
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
FOSL2 promotes leptin gene expression in human and mouse adipocytes
2012
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles
2009
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
2010
Binding of Transforming Growth Factor-β to Cell Surface Proteins Varies with Cell Type
1989
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Leptin potentiates the anti-obesity effects of rimonabant
2011
Negative regulation of transforming growth factor-β by the proteoglycan decorin
1990 StandoutNature
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
Pharmacological management of appetite expression in obesity
2010
Gut hormones: Implications for the treatment of obesity
2009
Tyrosine Phosphorylation of Syndecan-1 and -4 Cytoplasmic Domains in Adherent B82 Fibroblasts
1998
Magnetic Colloids As Drug Vehicles
2007
Validation of High Gradient Magnetic Field Based Drug Delivery to Magnetizable Implants Under Flow
2008
Functional Characterization of Mouse Syndecan-1 Promoter
1996
Leptin at 14 y of age: an ongoing story
2009
CNS-targets in control of energy and glucose homeostasis
2009
PVP magnetic nanospheres: Biocompatibility, in vitro and in vivo bleomycin release
2006
Magnetic nanoparticles and their applications in image-guided drug delivery
2011
What We Talk About When We Talk About Fat
2014 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Cellular bioenergetics as a target for obesity therapy
2010
A new class of membrane-bound chemokine with a CX3C motif
1997 StandoutNature
Chinese hamster ovary cell adhesion to human platelet thrombospondin is dependent on cell surface heparan sulfate proteoglycan.
1989
Organic Switches for Surfaces and Devices
2012 StandoutNobel
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
2007 Standout
Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney
1989
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Prediabetes: a high-risk state for diabetes development
2012 Standout
Obesity and leptin resistance: distinguishing cause from effect
2010
Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
1998 StandoutNature
Magnetic nanoparticles for drug delivery
2006
Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain.
1987
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
TGF-β SIGNAL TRANSDUCTION
1998 Standout
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
1999 StandoutScience
Gut Peptides: Targets for Antiobesity Drug Development?
2009
Characterization of Amylin and Calcitonin Receptor Binding in the Mouse α-Thyroid-Stimulating Hormone Thyrotroph Cell Line*
1997
Endogenous endostatin inhibits choroidal neovascularization
2007
Developmental biology of the pancreas
1995
Magnetic targeting for site-specific drug delivery: applications and clinical potential
2009
Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior.
1994
Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages
1993
Growth factors induce 3T3 cells to express bFGF-binding syndecan.
1992
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation
1998
Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor.
1989
Enhancing and targeting nucleic acid delivery by magnetic force
2003
Embryonic neural retinal cell response to extracellular matrix proteins: developmental changes and effects of the cell substratum attachment antibody (CSAT).
1987
Fibronectin stimulates macrophage uptake of low density lipoprotein-heparin-collagen complexes.
1988
Syndecan-4 Is a Primary-Response Gene Induced by Basic Fibroblast Growth Factor and Arterial Injury in Vascular Smooth Muscle Cells
1997
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Progress in applications of magnetic nanoparticles in biomedicine
2009
Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent
1996
Restoration of leptin responsiveness in diet‐induced obese mice using an optimized leptin analog in combination with exendin‐4 or FGF21
2012
Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.
1994
Molecular cloning of syndecan, an integral membrane proteoglycan.
1989
Temperature-Responsive Magnetite/PEO−PPO−PEO Block Copolymer Nanoparticles for Controlled Drug Targeting Delivery
2007
Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix
1988
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
2005
Expression of syndecan, a putative low affinity fibroblast growth factor receptor, in the early mouse embryo
1991
Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.
1989
Expression of syndecan-1 inhibits cell invasion into type I collagen.
1994
Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells.
1995
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Application of high gradient magnetic separation principles to magnetic drug targeting
2004
Transforming growth factor-β (TGF-β) receptor proteoglycan
1989
Syndecan-1 Expression Is Down-regulated during Myoblast Terminal Differentiation
1997
The extracellular matrix geneFrem1is essential for the normal adhesion of the embryonic epidermis
2004 StandoutNobel
Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1
1996
B lymphocytes express and lose syndecan at specific stages of differentiation.
1989
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts: implications for their roles in cell-substratum adhesion
1993
Inflammation- and ischemia-induced shedding of venular glycocalyx
2004
Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent: 1. Parametric study with single wire correlation
2004
Binding of heparan sulfate to type V collagen
1989
The high molecular weight receptor to transforming growth factor-beta contains glycosaminoglycan chains.
1988
Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading
1994
A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling.
1995
Casting Metal Nanowires Within Discrete Self-Assembled Peptide Nanotubes
2003 StandoutScience
Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells.
1996
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
2004
The 3D profile method for identifying fibril-forming segments of proteins
2006 StandoutNobel
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Challenges in the development of magnetic particles for therapeutic applications
2008
Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells.
1986
Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells.
1993
The Molecular Biology of Axon Guidance
1996 StandoutScience
A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence.
1987
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells.
1986
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016
Targeted drug delivery to magnetic implants for therapeutic applications
2005
Differential expression of transmembrane proteoglycans in vascular smooth muscle cells.
1993
Thrombospondin stimulates motility of human neutrophils.
1990 StandoutNobel
Magnetic nanoparticles for gene and drug delivery
2008
Tuning the Grain Size and Particle Size of Superparamagnetic Fe3O4 Microparticles
2009
Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
2013
Mechanisms of Nucleation and Growth of Nanoparticles in Solution
2014 Standout
New Perspectives in Cell Adhesion: RGD and Integrins
1987 StandoutScience
Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells.
1988
Induced expression of syndecan in healing wounds.
1991
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Magnetic nanoparticles for drug delivery
2007
The period clock locus of D. melanogaster codes for a proteoglycan
1986 StandoutNobel
Works of Joy E. Koda being referenced
Amylin-Mediated Restoration of Leptin Responsiveness in Diet-Induced Obesity: Magnitude and Mechanisms
2008
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
2008
The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans.
1985
Heparan sulfate proteoglycans from mouse mammary epithelial cells. Basal extracellular proteoglycan binds specifically to native type I collagen fibrils.
1984
Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens.
1985
Structure and biology of amylin
1993
Molecular physiology of amylin
1994
Interaction of Leptin and Amylin in the Long‐term Maintenance of Weight Loss in Diet‐induced Obese Rats
2009
Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC)
2001
Hepatocellular Carcinoma: Regional Therapy with a Magnetic Targeted Carrier Bound to Doxorubicin in a Dual MR Imaging/ Conventional Angiography Suite—Initial Experience with Four Patients
2004
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
2009
Remodelling of the Basement Membrane: Morphogenesis and Maturation
1984
Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin
1996